Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice...

  • Main
  • 2018 / 11
  • Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice...

Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST Trials

Fulcher, Greg, Mehta, Roopa, Fita, Edmond G., Ekelund, Magnus, Bain, Stephen C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Diabetes Therapy
DOI:
10.1007/s13300-018-0531-0
Date:
November, 2018
File:
PDF, 808 KB
english, 2018
Conversion to is in progress
Conversion to is failed